¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"end labeling"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end-to-end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¸Â¹°¸², ´Ü´Ü±³ÇÕ
  • cell labeling technique
    ¼¼Æ÷Ç¥Áö±â¹ý
  • enzyme labeling
    È¿¼ÒÇ¥Áö
  • ferritin labeling
    Æä¸®Æ¾Ç¥Áö
  • image labeling
    ¿µ»óºÎȣȭ, ¿µ»óÇ¥Áö
  • labeling
    Ç¥Áö, À̸§Ç¥´Þ±â
  • peroxidase labeling
    °ú»êÈ­È¿¼ÒÇ¥Áö
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
  • end
    ³¡, Á¾¸», ¸»´Ü
  • end apparatus
    Á¾¸»ÀåÄ¡
  • end artery
    ³¡µ¿¸Æ
  • end group
    ¸»´Ü±â
  • end organ
    Á¾¸»±â°ü
  • end organ deafness
    Á¾¸»±â°ü³­Ã»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end organ
    Á¾¸»±â°ü
  • end product
    ÃÖÁ¾»ê¹°
  • positive end expiratory pressure
    ³¯¼û³¡¾ç¾Ð, È£±â¸»¾ç¾Ð
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end to end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¹°¸², ´Ü´Ü±³ÇÕ
  • cell labeling technique
    ¼¼Æ÷Ç¥Áö±â¹ý
  • enzyme labeling
    È¿¼ÒÇ¥Áö
  • ferritin labeling
    Æä¸®Æ¾Ç¥Áö
  • image labeling
    ¿µ»óºÎȣȭ
  • labeling
    Ç¥Áö
  • peroxidase labeling
    °ú»êÈ­È¿¼ÒÇ¥Áö
  • trace labeling
    ÃßÀûÇ¥Áö
  • acromial end
    ºÀ¿ì¸®³¡
  • apical end
    ²ÀÁö³¡
  • end apparatus
    Á¾¸»ÀåÄ¡
  • end artery
    ³¡µ¿¸Æ
  • end to side anastomosis
    ³¡¿·¿¬°á(¼ú), ´ÜÃø¿¬°á(¼ú)
  • Krause¡¯s end bulb
    Å©¶ó¿ìÁ¦³¡¸Á¿ï
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • image labeling
    ¿µ»óÀÇ ºÎȣȭ
  • Krause s end bulbs
    Å©¶ó¿ìÁ¦Á¾¸»±¸.
  • Krauses end bulb
    Å©¶ó¿ìÁ¦Á¾¸»±¸
  • MEPP=>miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀü¾Ð
  • MEPP=£¾miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀüÀ§.
  • PEEP(positive end-expiratory pressure)
    È£±â¸» ¾ç¾ÐÈ£Èí
  • acromial end
    ºÀ¿ì¸®³¡
  • advanced glycosylation end products
    ÁøÇ༺´çÈ­Á¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡.
  • hair on end pattern
    °ïµÎ¼± ¸ð¹ß ÇüÅÂ
  • positive end expiratory pressure =PEE
    È£±â¸»¾ç¾Ð.
  • positive end expiratory pressure =PEEP
    È£±â¸»¾ç¾Ð.
  • proximal end
    ±ÙÀ§´Ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú.
  • end-to-end bite =e. occlusion
    ´Ü´Ü±³ÇÕ.
  • end-to-end implantation
    ´Ü´Ü»ðÀÔ¼ú
  • image labeling
    ¿µ»óÀÇ ºÎȣȭ
  • labeling
    ³«ÀÎ(ÑäìÔ)
  • tagging ; labeling
    Ç¥Áö(øöãÛ).
  • acromial end
    ºÀ¿ì¸®³¡
  • advanced glycosylation end products
    ÁøÇ༺´çÈ­Á¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
  • double-end graft
    ½Ö´ÜÀ̽Ä.
  • end apparatus
    Á¾¸»ÀåÄ¡(ðûØÇíûöÇ).
  • end artery
    Á¾µ¿¸Æ(ðûÔÑØæ).
  • end bulb of Krause
  • end dilution value =EDV
    ü¿ÜÈñ¼®Ä¡(ô÷èâýüà·ö·).
  • end feet
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Sternal end
    º¹À峡
    [¿¾ ¿ë¾î] Èä°ñ´Ü
  • Acromial end
    ºÀ¿ì¸®³¡
    [¿¾ ¿ë¾î] °ßºÀ´Ü
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] ¸»´ÜºÎ
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] Á¾¸»ºÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apical end
    ÷´ÜºÎ
  • end group spine
    ±ê³¡°¡½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end labeling
    Á¾´ÜÇ¥Áö (ðûÓ®øöò½)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • covalent labeling
    °øÀ¯°áÇÕ Ç¥Áö(ÍìêóÌ¿ùêøöòµ) (ÔÒ) affinity labeling
  • differential labeling
    °¨º° Ç¥Áö(Êüܬøöò½)
  • enzyme labeling
    È¿¼ÒÇ¥Áö(ý£áÈøöò½)
  • negative labeling
    ¿ªÇ¥Áö(æ½øúòµ)
  • pseudophotoaffinity labeling
    À§±¤Ä£È­ Ç¥Áö(êÊÎÃöÑûúøöò½)
  • randomly labeling
    ÀϹÝÀûÇ¥Áö(ìéÚõîÜøöò½)
  • spin labeling
    ½ºÇÉ Ç¥Áö(øöò½)
  • advanced glycosylation end product
    ÁøÇà ´çÈ­Á¾»ê¹°(òäú¼ÓØûùðûß§Úª)
  • blunt end ligation
    µÐ´Ü¿¬°á(ÔïÓ®Ö§Ì¿)
  • blunt end
    µÐ´Ü(ÔïÓ®)
  • capped 5'-end
    ĸ °áÇÕ(Ì¿ùê)-5'-Á¾´Ü(ðûÓ®)
  • CCA-end
    CCA Á¾´Ü(ðûÓ®)
  • cohesive end
    Á¡ÂøÁ¾´Ü(ïÄó·ðûÓ®)
  • cohesive end ligation
    Á¡ÂøÁ¾´Ü°áÂû(ïÄó·ðûӮ̿óÎ)
  • dead-end complex
    Á¾¸»º¹ÇÕü(ðûØÇÜÜùêô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • image labeling
    ¿µ»óÀÇ ºÎȣȭ
  • tagging;labeling
    Ç¥Áö
  • end artery
    Á¾µ¿¸Æ
  • hair on end pattern
    °ïµÎ¼±¸ð¹ßÇüÅÂ
  • upper end
    »ó¿¬
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
EE embryo extract; end-to-end; end expiration; energy expenditure; Enterobacteriaceae enrichment [broth...
APAAP alkaline phosphatase-antialkaline phosphatase [labeling]
LI labeling index; lactose intolerance; lacunar infarct; lamellar ichthyosis; Langerhans islet; large i...
PCLI plasma cell labeling index
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TUNEL 5-triphosphate (dUTP)-biotin nick end-labeling
TUNEL TDT)-mediated dUTP-biotin nick end labeling
TUNEL TDT)-mediated dUTP-digoxigenin nick end labeling
TUNEL TdT-dUTP terminal nick-end labeling
TUNEL Transferase-Mediated dUTP Nick End Labeling
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • end to end relationship
    Àý´Ü¸é°ú Àý´Ü¸é °ü°è
  • end-to-end
    ³¡°ú ³¡ÀÌ Á¢ÇÑ, öÀúÈ÷, »ô»ôÀÌ
  • end-to-end bite
    ´Ü´Ü ±³ÇÕ
    µ¿ÀǾî=end-to-end occlusion.
  • end-to-end suture
    Àý´Ü´ë Àý´Ü ºÀÇÕ
  • image labeling
    ¿µ»óÀÇ ºÎȣȭ
  • advanced glycosylation end products
    ÁøÇ༺ ´çÈ­ Á¾¸» »ý¼º¹°
  • central end
    Á᫐ ¸»´Ü
  • end apparatus
    Á¾¸» ÀåÄ¡
  • end feel
    Á¾¸»°¨, Á¾¸» °¨°¢
  • end path
    Á¾·Î
  • end-expiration
    È£Èí °áÇ٠ȣ±â ¸»±â
  • end-feel
    Á¾¸»°¨
    ¿ÏÀüÇÑ ´Éµ¿ °³±¸·ÎºÎÅÍ ¿ÏÀüÇÑ ¼öµ¿ °³±¸±îÁö °üÀýÀ» ¼ÕÀ¸·Î Á¶ÀÛÇÏ´Â µ¿¾È ´À²¸Áö´Â ÀúÇ×°¨.
  • end-organ
    Á¾¸» ±â°ü, ¸»´Ü±â, Á¾¸» ½Å°æ ¼Òü
    Áö°¢ ½Å°æÀÇ ÇÇÆ÷µÈ Ä¿´Ù¶õ Á¾¸»ºÎ.
  • free end saddle partial denture
    À¯¸®´Ü ±¹ºÎ ÀÇÄ¡
    ¾Ç±ÃÀÇ ÈĹ濡 ÀÜÁ¸Ä¡°¡ ÆíÃø ¶Ç´Â ¾çÃø¼ºÀ¸·Î ¾øÀ» ¶§ Á¦ÀÛµÈ ±¹¼Ò ÀÇÄ¡ÀÌ´Ù.
  • joint end-feel
    °üÀý Á¾¸»°¨
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
end-to-end bite An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
end-to-end occlusion An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
affinity labeling <technique> A method for tagging molecules, such as enzymes, so that they can be more easily detected and studied. The method works by substituting a synthetic substance which is similar to the substance that the enzyme normally bonds with.
(09 Feb 1998)
chemiluminescent labeling A technique of labeling DNA strands, two different DNA probes emit light when they come together in the same region of a gene.
(09 Oct 1997)
product labeling Use of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. It includes purpose, effect, description, directions, hazards, warnings, and other relevant information.
(12 Dec 1998)
isotope labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labelled substances unless the methods of labeling are substantively discussed. Tracers that may be labelled include chemical substances, cells, or microorganisms.
(12 Dec 1998)
food labeling Use of written, printed, or graphic materials upon or accompanying a food or its container or wrapper. The concept includes ingredients, nutritional value, directions, warnings, and other relevant information.
(12 Dec 1998)
acromial end of clavicle The flattened lateral end of the clavicle that articulates with the acromion and is anchored to the coracoid process by the conoid and trapezoid ligaments.
Synonym: extremitas acromialis claviculae, acromial end of clavicle.
(05 Mar 2000)
blunt-end Refers to double-stranded DNA in which there are no unpaired bases at the end.
(05 Mar 2000)
blunt-end DNA <molecular biology> A fragment of a DNA molecule in which the ends of both strands are even with each other rather than one strand being longer than the other.
(09 Oct 1997)
blunt-end ligation A lab technique to join together two pieces of blunt-end DNA, such as an insert into a cloning vector, which requires the enzyme ligase because there are no single-stranded overhanging ends for the attachment to form more spontaneously, by itself.
(09 Oct 1997)
by-end Private end or interest; secret purpose; selfish advantage.
Alternative forms: bye-end.
(20 Mar 1998)
capped 5'-end A methylated (has a -CH3 attached) guanosine nucleotide attached to the 5'-end (the beginning) of an eukaryotic mRNA, thought to give the mRNA stability.
(09 Oct 1997)
glycosylation end products, advanced Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus.
(12 Dec 1998)
root end cyst An inflammatory odontogenic cyst derived histogenetically from Malassez' epithelial rests surrounding the root apex of a nonvital tooth.
Synonym: periapical cyst, radicular cyst, root end cyst.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • by-end
    À̱âÀûÀÎ µ¿±â
  • end
    ³¡,¸ñÀû,°á¸»
  • to the end
    ³¡±îÁö
  • END
    European Nuclear Disarmament
  • East End
    ·±´ø µ¿Á· ³¡(ÀÌÀüÀÇ ºó¹Î°¡)
  • Land's End
    ¿µ±¹ Cornwall ÁÖ ¼­´ÜÀÇ ²É
  • book end
    ºÏ¿£µå(Ã¥²ÉÀÌÀÇ ÀÏÁ¾)
  • butt end
    ±½ÀºÂÊÀdz¡;±×·çÅͱâ;³²Àº ºÎºÐ(Á¶°¢)
  • closed-end
    (ÅõÀÚ ½ÅŹÀÌ)ÀÚº»¾× °íÁ¤ÀÎ;Æó¼â½ÄÀÎ;(´ãº¸°¡)´ëºÎ ±Ý¾×À» °íÁ¤½ÃŲ
  • closed-end bond fund
    Æó¼âÇü ä±Ç ÆÝµå
  • closed-end investment company
    Æó¼âÇü ÅõÀÚ ½ÅŹ ȸ»ç
  • dead end
    ¸·´Ù¸¥ µ¥
  • dog end
    ´ã¹è ²ÇÃÊ
  • end
    ³¡;¸¶Áö¸·;Á¾¸»;¸ñÀû;°á°ú;Á¶°¢;ÀüÀ§;ºóµÕºóµÕ;¹ÌÇØ°á·Î;¾îÂîÇÒ ¹Ù¸¦ ¸ð¸£°í;¹«Á÷À¸·Î;»ê¶õÇÏ¿©;³¡¸¶Ä¡´Ù;±×¸¸µÎ´Ù;Á×ÀÌ´Ù
  • end around
    (¹Ì)¿£µå ¾î¶ó¿îµå(º¼À» ¹ÞÀº °ø°ÝÆÀÀÇ end°¡ ¶óÀÎ ¹Ý´ëÃøÀ¸·Î ¿ìȸÇÏ¿© ÀüÁøÇÏ´Â Æ®¸¯ Ç÷¹ÀÌ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á